The store will not work correctly when cookies are disabled.
1-Ethyl-5-(p-tolyl)furo[3',4':5,6]pyrido[2,3-d]pyrimidine-2,4,6-(1H,3H,8H)-trione
ID: ALA4067951
PubChem CID: 137632690
Max Phase: Preclinical
Molecular Formula: C18H15N3O4
Molecular Weight: 337.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCn1c(=O)[nH]c(=O)c2c(-c3ccc(C)cc3)c3c(nc21)COC3=O
Standard InChI: InChI=1S/C18H15N3O4/c1-3-21-15-14(16(22)20-18(21)24)12(10-6-4-9(2)5-7-10)13-11(19-15)8-25-17(13)23/h4-7H,3,8H2,1-2H3,(H,20,22,24)
Standard InChI Key: XQIVSOWGERBFQG-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
13.0085 -12.4759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3114 -12.9006 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.5948 -12.5043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5795 -11.6873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2766 -11.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9932 -11.6589 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8630 -11.2910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1617 -11.7116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1770 -12.5286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8936 -12.9249 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9124 -12.1439 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3816 -11.4753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4073 -12.7973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7250 -12.8722 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2613 -10.4497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1128 -10.7055 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8477 -10.4740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1311 -10.0777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8171 -8.8401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5448 -10.0534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1158 -9.2607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5295 -9.2364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8018 -8.0231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3267 -13.7176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0391 -14.1098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
9 10 1 0
11 12 1 0
11 13 1 0
8 12 1 0
9 13 1 0
3 10 2 0
4 7 2 0
1 14 2 0
5 15 2 0
12 16 2 0
17 18 1 0
17 20 2 0
18 21 2 0
19 21 1 0
19 22 2 0
20 22 1 0
19 23 1 0
7 17 1 0
24 25 1 0
2 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 337.34 | Molecular Weight (Monoisotopic): 337.1063 | AlogP: 1.75 | #Rotatable Bonds: 2 |
Polar Surface Area: 94.05 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.86 | CX Basic pKa: 0.03 | CX LogP: 2.14 | CX LogD: 2.13 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.72 | Np Likeness Score: -0.68 |
References
1. Ayoub AM, Hawk LML, Herzig RJ, Jiang J, Wisniewski AJ, Gee CT, Zhao P, Zhu JY, Berndt N, Offei-Addo NK, Scott TG, Qi J, Bradner JE, Ward TR, Schönbrunn E, Georg GI, Pomerantz WCK.. (2017) BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen., 60 (12): [PMID:28535045] [10.1021/acs.jmedchem.6b01336] |